The CYP17A1 gene gives your body instructions for making an enzyme that helps produce steroid hormones, including cortisol and sex hormones. This gene plays an important role in hormone balance for blood pressure, puberty, fertility, and sexual development. If the CYP17A1 gene does not work properly, people may have low sex hormone levels, delayed puberty, differences in genital development, and sometimes high blood pressure with low potassium. Certain harmful variants can cause a form of congenital adrenal hyperplasia, a genetic condition affecting hormone production.
What is a gene?
A gene is a section of DNA that carries instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, the parts of cells that do much of the work. Others are mainly involved in controlling when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can also influence how you respond to food, stress, or medicines. For a more in depth look at this topic, you can find more information in the LearnHub.
Overview
CYP17A1Gene function
What if the gene works
The CYP17A1 gene helps the adrenal glands and ovaries or testes make steroid hormones. These hormones include cortisol, which supports stress response, and sex hormones needed for puberty, fertility, and many body functions.
Risk
What if the gene does not work
Variants that reduce activity of the CYP17A1 gene can lower cortisol and sex hormone production, causing congenital adrenal hyperplasia. Effects range from milder to more severe and may include high blood pressure, delayed puberty, and differences in sex development.
Treatment
What does that mean for your treatment
Pathogenic or loss-of-function variants in the CYP17A1 gene usually guide treatment toward glucocorticoid replacement, which lowers ACTH (a hormone that stimulates the adrenal glands) and can help control blood pressure and low potassium. Many people also need sex hormone replacement matched to their body’s needs, often around puberty or adulthood. Some may also use blood pressure medicines such as spironolactone or eplerenone.
Conditions associated with CYP17A1
Gene function
What if the gene works
Many everyday body functions depend on the CYP17A1 gene helping your cells make steroid hormones. Its protein is most active in the adrenal glands and in the ovaries or testes. This is central to how the CYP17A1 gene helps make steroid hormones that support stress responses and reproduction.
The CYP17A1 gene gives cells instructions for an enzyme that reshapes cholesterol based hormone building blocks. This work happens mainly in the adrenal glands and in the ovaries or testes.
The CYP17A1 gene helps turn early steroid building blocks into forms that can be used to make cortisol. Cortisol helps your body manage daily stress, maintain blood pressure, and keep blood sugar in a healthy range.
The CYP17A1 gene helps cells make the starting materials for testosterone and estrogen. These hormones support puberty, fertility, menstrual cycles, sperm production, and many normal body changes over time.
What is a variant?
A genetic variant is a slight difference in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. Sometimes, however, a variant changes how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CYP17A1 gene can change the shape or stability of the enzyme it encodes, so cells make less of one or both hormone-building activities. In how CYP17A1 variants affect steroid hormone production, some single-letter DNA changes leave partial function, while more disruptive variants can greatly reduce or stop enzyme activity. This spectrum often influences how much cortisol and sex steroid synthesis is impaired and, in CYP17A1-related deficiency, may shape when features appear and how pronounced they are.
How variants are linked to conditions
Pathogenic variants in the CYP17A1 gene can cause 17α-hydroxylase/17,20-lyase deficiency, a rare form of congenital adrenal hyperplasia. CYP17A1 gene variants and congenital adrenal hyperplasia are linked through a pattern that may include high blood pressure, low potassium, delayed puberty, infertility, and differences in sex development. Some common CYP17A1 gene variants have also been associated with small changes in blood pressure risk, but these findings do not mean hypertension is certain.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition points to a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For health problems linked to the CYP17A1 gene, risk is mainly shaped by the gene changes inherited at birth rather than by lifestyle. The chance is higher when both parents carry a harmful CYP17A1 variant, especially in families with a known history of the condition or when parents are blood relatives.
Inheritance of CYP17A1 variants
Variants in the CYP17A1 gene are inherited in an autosomal recessive pattern for the well-established conditions linked to this gene. This means a child usually inherits one CYP17A1 gene variant from each parent. Parents who each carry one variant often do not have the condition themselves, but with each pregnancy there is a 25% chance the child will inherit both variants, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither variant. In practical terms, CYP17A1 gene inheritance usually matters when both parents carry a variant in the same gene.
What does my CYP17A1 result mean for my family?
For CYP17A1, family implications are usually discussed in the context of a recessive condition. This often means parents can be healthy carriers, while brothers or sisters may also have the condition or be carriers. Other relatives may also carry the same gene change, so the result can matter for family planning and for understanding similar health findings in the family.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the CYP17A1 gene, clinicians use genetic testing for CYP17A1 variants on a blood or saliva sample. A lab reads the gene’s DNA code and checks for variants, which can help confirm a suspected diagnosis or show whether you carry a known family variant.
When should I consider getting a genetic test?
Consider CYP17A1 testing if you or your child has signs of a rare adrenal hormone condition, such as delayed puberty, high blood pressure with low potassium, or differences in sex development. It can also help when a close family member has a known CYP17A1 variant or the condition runs in the family.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they reveal depends on the condition and the type of variant involved. Many factors, including age, environment, lifestyle, and medical history, also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles a medicine, so the same treatment may work well for one person but less well for another. Some people break down a drug more slowly or more quickly, while others are more sensitive to its effects. These differences are common and can influence how much benefit a treatment gives or how likely side effects are.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect the way they respond to medicines. It studies connections between genes and medications to help explain why the same treatment can work differently from one person to another. For many drugs, genes influence how strongly a medicine works or how the body handles it. This information can support more informed, individualized treatment decisions. To explore this topic in more detail, you can learn more in the LearnHub.
Drugs influenced by the CYP17A1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding routine medication choices, so questions about medicines or side effects are best discussed with your doctor. CYP17A1 has been studied in hormone-related treatments, including prostate cancer therapy, but this research has not led to widely used prescribing guidelines.
History
CYP17A1 entered medical genetics through studies of rare hormone-related conditions that puzzled doctors for decades. Initially understood only through visible traits, later recognized as tied to a specific gene, this story moved from endocrinology clinics to molecular genetics labs. In the 1960s and 1970s, researchers linked a specific enzyme problem to unusual patterns of blood pressure, puberty, and sexual development. Building on this early work, scientists identified and cloned the CYP17A1 gene in the late 1980s, which made direct genetic testing possible. That discovery helped connect earlier clinical observations with inherited variants and shaped modern understanding of several adrenal and reproductive conditions.